Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-03-22
1995-02-14
Henley, III, Raymond J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514259, 544284, 544285, 540570, A61K 3155, A61K 31505, C07D24314, C07D23980
Patent
active
053896319
ABSTRACT:
Fibrinogen receptor antagonists of the ##STR1## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets wherein G is: ##STR2## for example, ##STR3##
REFERENCES:
patent: 4122255 (1978-10-01), Krapcho
patent: 4243807 (1981-01-01), Frieb et al.
patent: 4313947 (1982-02-01), Nakagawa et al.
patent: 4622331 (1986-11-01), Jozic
patent: 5030654 (1991-07-01), Barnish
Claremon David A.
Liverton Nigel
Henley III Raymond J.
Matukaitis Paul D.
Merck & Co. , Inc.
Parr Richard S.
Spivack Phyllis G.
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-288200